Showing posts with label
CytoDyn
.
Show all posts
Showing posts with label
CytoDyn
.
Show all posts
Friday, February 5, 2021
CytoDyn Inc.’s Vyrologix™ (leronlimab-Vyrologix) shows impressive results in critically ill COVID-19 patients
›
CytoDyn Inc., a late-stage biotechnology company developing CCR5 inhibiting drug leronlimab- Vyrologix, showed impressive results in improvi...
›
Home
View web version
